Hideki Kanda
Impact in
- Accounting top 5%
- Corporate Finance and Governance
- Corporate Insolvency and Governance
- Strategy and Management top 10%
- Corporate Governance and Law
Papers in
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 7
- Renal cell carcinoma treatment 4
-
- Corporate Governance and Law 8
- Co-authors
- Yoshiki Sugimura (34 shared papers)Kiminobu Arima (31 shared papers)Kenichiro Ishii (16 shared papers)Klaus J. Hopt (6 shared papers)Curtis J. Milhaupt (2 shared papers)Manabu Kato (17 shared papers)Takeshi Sasaki (19 shared papers)Eddy O. Wymeersch (3 shared papers)
- Journals
- The Journal of Urology (3 papers)Cancer Prevention Research (2 papers)Laboratory Investigation (2 papers)Journal of Clinical Medicine (2 papers)The American Journal of Comparative Law (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hideki Kanda
71 papers receiving 728 citations
Peers
Comparison fields: 5 of 106
- Accounting 177
- Strategy and Management 130
- Finance 65
- Pulmonary and Respiratory Medicine 195
- Urology 26
Countries citing papers authored by Hideki Kanda
This map shows the geographic impact of Hideki Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Kanda more than expected).
Fields of papers citing papers by Hideki Kanda
This network shows the impact of papers produced by Hideki Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Kanda. The network helps show where Hideki Kanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Kanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Anatomy of Corporate Law: A Comparative and Functional Approach | 2009 | 94 |
| 2 | 2007 | 57 | |
| 3 | 2005 | 54 | |
| 4 | 2013 | 52 | |
| 5 | 2011 | 45 | |
| 6 | 2007 | 36 | |
| 7 | 2003 | 35 | |
| 8 | 2020 | 31 | |
| 9 | 2018 | 28 | |
| 10 | Fibrolamellar carcinoma of the liver. | 1999 | 24 |
| 11 | 2013 | 20 | |
| 12 | The Stock Exchange as a Firm: The Emergence of Close Substitutes for the New York and Tokyo Stock Exchanges | 1990 | 19 |
| 13 | 2019 | 18 | |
| 14 | 2017 | 16 | |
| 15 | 2000 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2017 | 15 | |
| 18 | 2013 | 13 | |
| 19 | 2019 | 13 | |
| 20 | 2008 | 12 |
About Hideki Kanda
Hideki Kanda is a scholar working on Pulmonary and Respiratory Medicine, Strategy and Management, Urology, Accounting and Surgery, having authored 81 papers that have together received 807 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Corporate Governance and Law (8 papers), Urological Disorders and Treatments (7 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Corporate Insolvency and Governance (6 papers), Corporate Law and Human Rights (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Accounting (177 citations), Strategy and Management (130 citations), Finance (65 citations), Pulmonary and Respiratory Medicine (195 citations) and Urology (26 citations). Hideki Kanda has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yoshiki Sugimura, Kiminobu Arima, Kenichiro Ishii, Klaus J. Hopt, Curtis J. Milhaupt, Manabu Kato, Takeshi Sasaki, Eddy O. Wymeersch, Masahiro Kanai and John H. Armour. Their work appears in journals such as The Journal of Urology, Cancer Prevention Research, Laboratory Investigation, Journal of Clinical Medicine and The American Journal of Comparative Law.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.